← All organizations

Gem Pharmaceuticals

For profit

Highest phase reached

Phase 2

First clinical trial

Jun 1, 2003

Last known activity

Jan 7, 2015

Acquired by Monopar Therapeutics on Nov 14, 2017

Timeline

2000s

  1. Jun 1, 2003

    Gem Pharmaceuticals— Founded

2010s

  1. Nov 14, 2017

    Monopar Therapeutics— Acquired By

Drugs by trial phase (2 distinct, 4 trials)

Phase 2 (2 own, 0 via acquisition)

Indications

Recent trials (5)

Details

Founded
Birmingham, AL, US Jun 1, 2003
Last known activity
Jan 7, 2015